Taqman 5′-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening

Journal of Clinical Microbiology

Volumn 39, Issue 12, 2001, Pages 4302-4308

  Drosten, C ^a   Seifried, E ^a   Roth, W K ^a  

^a Inst Transfusionsmed/Immunhamatol   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FLUORESCENT DYE; GAG PROTEIN; RIBONUCLEASE; VIRUS DNA; VIRUS RNA; TAQ POLYMERASE;

ARTICLE; BACTERIOPHAGE; BLOOD DONOR; CENTRIFUGATION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; VALIDATION PROCESS; VIRUS DETECTION; BLOOD; COLIPHAGE; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; MASS SCREENING; METABOLISM; METHODOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIROLOGY;

BLOOD DONORS; COLIPHAGES; HIV INFECTIONS; HIV-1; HUMANS; MASS SCREENING; POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TAQ POLYMERASE;

EID: 0034747327     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.12.4302-4308.2001     Document Type: Article

References (23)

1. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors
2. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
3. Coamplified positive control detects inhibition of polymerase chain reaction
4. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
5. Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening
6. Using PCR to engineer DNA
7. Detection of specifi6 polymerase chain reaction product by utilizing the 5′ to 3′-exonuclease activity of Thermus aquaticus DNA polymerase
8. Optimization of PCRs
9. A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples
10. Avoiding false positives with PCR
11. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
12. Redefining the HIV-infectious window period in the chimpanzee model: Evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission
13. Armored RNA technology for production of ribonuclease-resistant viral RNA control and standards
14. Duration of time from onset of human immunodeficiency virus type 1 infection to development of detectable antibody
15. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR
16. An internal control for routine diagnostic PCR: Design, properties, and effect on clinical performance
17. Feasibility and efficacy of routine PCR screening of plasma from donors for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood bank setting
18. Quantification of hepatitis C virus by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus transcript
19. The risk of transfusion-transmitted viral infections
20. Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens
21. Zwischenmolekulare Energiewanderung und Fluoreszenz
22. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody